Working… Menu

Safety Study on AdCD40L Gene Therapy for Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00891748
Recruitment Status : Completed
First Posted : May 1, 2009
Last Update Posted : January 18, 2010
Uppsala University Hospital
Information provided by:
Uppsala University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2009
Actual Study Completion Date : October 2009